Angiotensin-converting enzyme inhibitors: Are there credible mechanisms for beneficial effects in diabetic neuropathy?

被引：0
|
作者：
Malik, RA [1 ]
Tomlinson, DR [1 ]
机构：
[1] Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
来源：
NEUROBIOLOGY OF DIABETIC NEUROPATHY | 2002年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：415 / 430
页数：16
相关论文
共 50 条
  • [1] Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?
    Malik, RA
    ANNALS OF MEDICINE, 2000, 32 (01) : 1 - 5
  • [2] Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization
    Lazar, HL
    Volpe, C
    Bao, YS
    Rivers, S
    Vita, JA
    Keaney, JF
    ANNALS OF THORACIC SURGERY, 1998, 66 (02) : 487 - 492
  • [3] Dual beneficial effect of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in diabetic nephropathy
    Ljubic, S
    Bozikov, J
    Kljajlc, K
    Pavlic-Renar, I
    Vucic-Lovrencic, M
    Metelko, Z
    DIABETES, 2005, 54 : A199 - A199
  • [4] EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON THE PROGRESSION OF DIABETIC NEPHROPATHY
    RUILOPE, LM
    JOURNAL OF HYPERTENSION, 1995, 13 : S91 - S93
  • [5] ACUTE AND CHRONIC EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON TISSUE ANGIOTENSIN-CONVERTING ENZYME
    CHAI, SY
    PERICH, R
    JACKSON, B
    MENDELSOHN, FAO
    JOHNSTON, CI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1992, : 7 - 12
  • [6] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN DIABETIC NEPHROPATHY
    MELCHIOR, WR
    BINDLISH, V
    JABER, LA
    ANNALS OF PHARMACOTHERAPY, 1993, 27 (03) : 344 - 350
  • [7] Adverse effects of the angiotensin-converting enzyme inhibitors
    Alderman, CP
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (01) : 55 - 61
  • [8] Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients
    H. Yokoyama
    O. Tomonaga
    M. Hirayama
    A. Ishii
    M. Takeda
    T. Babazono
    U. Ujihara
    C. Takahashi
    Y. Omori
    Diabetologia, 1997, 40 : 405 - 411
  • [9] Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients
    Yokoyama, H
    Tomonaga, O
    Hirayama, M
    Ishii, A
    Takeda, M
    Babazono, T
    Ujihara, U
    Takahashi, C
    Omori, Y
    DIABETOLOGIA, 1997, 40 (04) : 405 - 411
  • [10] Class effects of angiotensin-converting enzyme inhibitors
    Sica, DA
    AMERICAN JOURNAL OF MANAGED CARE, 2000, 6 (03) : S85 - S108
12345